Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial (Q29620155)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 2 October 2010)

Language	Label	Description	Also known as
English	Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial	scientific article (publication date: 2 October 2010)

Statements

scholarly article

0 references

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial (English)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20888992

30 April 2017

prostate cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

antineoplastic resistance

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888992

25 July 2024

1

object named as

Johann Sebastian de Bono

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888992

25 July 2024

Mustafa Özgüroğlu

3

object named as

Mustafa Ozguroglu

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888992

25 July 2024

Steinbjørn Hansen

4

object named as

Steinbjørn Hansen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888992

25 July 2024

author name string

Machiels JP

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20888992

30 April 2017

Stephane Oudard

2

0000-0003-0893-285X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888992

25 July 2024

Jean-Pascal Machiels

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888992

25 July 2024

Ivo Kocak

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888992

25 July 2024

Gwenaëlle Gravis

7

0000-0002-3127-1554

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888992

25 July 2024

Istvan Bodrogi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888992

25 July 2024

Mary J. Mackenzie

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888992

25 July 2024

Liji Shen

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888992

25 July 2024

Martin Roessner

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888992

25 July 2024

Sunil Gupta

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888992

25 July 2024

A. Oliver Sartor

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888992

25 July 2024

TROPIC Investigators

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20888992

25 July 2024

language of work or name

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20888992

30 April 2017

publication date

2 October 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20888992

30 April 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S014067361061389X?httpAccept=text/xml

1 reference

10.1016/S0140-6736(10)61389-X

https://api.crossref.org/works/10.1016/S0140-6736(10)61389-X

25 July 2024

https://api.elsevier.com/content/article/PII:S014067361061389X?httpAccept=text/plain

1 reference

10.1016/S0140-6736(10)61389-X

https://api.crossref.org/works/10.1016/S0140-6736(10)61389-X

25 July 2024

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20888992

30 April 2017

376

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20888992

30 April 2017

9747

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20888992

30 April 2017

1147-54

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20888992

30 April 2017

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961389-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961389-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961389-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961389-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of Life and Pain in Advanced Stage Prostate Cancer: Results of a Southwest Oncology Group Randomized Trial Comparing Docetaxel and Estramustine to Mitoxantrone and Prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961389-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients : randomized phase 2 study of ixabepilone or mitoxantrone and prednisone.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961389-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961389-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Update on tubulin-binding agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961389-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacokinetic study of XRP6258 (RPR 116258A), a novel taxane, administered as a 1-hour infusion every 3 weeks in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961389-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961389-X

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961389-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The McGill Pain Questionnaire: Major properties and scoring methods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961389-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961389-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961389-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel induces apoptosis in hormone refractory prostate carcinomas during multiple treatment cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961389-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(10)61389-X

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20888992

30 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20888992

30 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q29620155&oldid=2212406821"